GlobeImmune (GBIM) - NASDAQ

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Company Description
GlobeImmune, Inc. is a biopharmaceutical company, which focuses on developing therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company has four product candidates in five ongoing clinical trials. It's cancer product candidate, GI-4000, is... More
Sector: Healthcare
Industry: Biotechnology
Country: United States